Spectrum Pharmaceutecals Inc (SPPI)

[Tartiaboy]

If your numbers are even in the ball park I'll consider Rolontis a major screw up. JT refuses to give numbers, but his enthusiasm and statements do not suggest such a low market penetration. I do think the street is in a "show me" status. NO value given to Rolontis, YET.

Why do you think JT got two Neulasts/Rolontis marketing experts onto the BOD? To support a $50M product?

I agree that JT is probably looking to out-license Qapzola after approval.

My concern is that if Rolontis and Qapzola are so-so products we are a ONE product company.

My hope is that SPPI has a workable strategy to take significant share from Neulasta. That's what JT has been signalling.